Abstract
Isoproterenol hydrochloride (ISO), a beta adrenergic agonist, is known to cause ischemic necrosis in rats. Cardiotoxicity of three different doses of ISO were studied using physiological, biochemical and histopathological parameters. The effects of single and double dose of ISO were analysed, which illustrated that single ISO dose was more cardiotoxic than double ISO dose due to ischemic preconditioning. The tetrapeptide derivatives L-lysine-L-arginine-L-aspartic acid-L-serine (tetrapeptide A) and di-tert.butyloxycarbonyl-L-lysine-L-arginine-L-aspartic acid-tert.butyl O-tert.butyl-L-serinate (tetrapeptide B) along with acetylsalicylic acid as positive control were analysed at different time points for their cardioprotective effect. The results demonstrated that optimal protective effects were observed by pretreatment with 5 mg/kg of tetrapeptide B and this was found to be slightly better than that of acetylsalicylic acid. A lesser degree of cardioprotection was noticed when low doses of tetrapeptide B were administered. This study clearly showed that single dose of ISO (50 mg/kg, s.c.) induced myocardial necrosis could be used as a model to assess cardiovascular drugs and in this model, it was demonstrated that the tetrapeptide B could exhibit optimal cardioprotective effect.
Similar content being viewed by others
References
Rona G, Chappel CI, Balazs T, Gaudry R: An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. Arch Pathol 67: 443-455, 1959
Wexler BC: Myocardial infarction in young vs. old male rats: Pathophysiologic changes. Am Heart J 96: 70-80, 1978
Karmazn M, Moffat MP, Beamish RE, Dhalla NS: Comparative effects of acetyl salicylic acid (ASA) and sulfinpyrazone on isoproterenol induced heart damage. J Pharmacol Exp Ther 218: 764-770, 1981
Singal PK, Kapur N, Dhillon KS, Beamish RE, Dhalla NS: Role of free radicals in catecholamine induced cardiomyopathy. Can J Physiol Pharmacol 60: 1390-1397, 1982
Cao AP, Loyzaga PG, Perer AM, Tamargo J: Effect of oxidipine and nitredipine on the size of experimental myocardial infarct in the rat. Pharmacol Toxicol 74: 321-329, 1994
Chappel CI, Rona G, Balazs T, Gaudry R: Severe myocardial necrosis produced by isoproterenol in the rat. Arch Intl Pharmacodyn Ther 122: 123-128, 1959
Davies MJ: The pathology of myocardial ischemia. J Clin Pathol 30: 45-52, 1977
Frishman WH, Burns B, Atac B, Alturk N, Altajar B, Lerrick K: Novel antiplatelet therapies for treatment of patients with ischemic heart disease: Inhibitors of the platelet glycoprotein IIb/IIIa integrin receptor. Am Heart J 130: 877-892, 1995
Hennekens CH, O'Donnell CJ, Ridker PM: Current and future perspectives on antithrombotic therapy of acute myocardial infarction. Eur Heart J 16(Suppl D): 2-9, 1995
Rihal CS, Flather M, Hirsh J, Yusuf S: Advances in antithrombotic drug therapy for coronary artery disease. Eur Heart J 16(Suppl D): 10-21, 1995
Lewis HD, Davis JW, Archibald DG: Protective effect of aspirin against acute myocardial infirction and death in men with unstable angina. Results of a Veterans Administration Cooperation Study. N Engl J Med 309: 396-403, 1983
Morishita K, Wada M, Kurnada T, Tanaka T, Tomikawa M, Iwamoto: Effect of ticlopidine and other antithrombotics on the venous thrombosis induced by endothelial damage of jugular vein in rats. Thromb Res 63: 373-384, 1991
Handin RI: Anticoagulant, fibrinolytic and antiplatelet therapy. In: K.J. Isselbacher, E. Braunwald, J.D. Wilson, J.B. Martin, A.S. Fauci, D.L. Kasper (eds). Harrison's Principle of Internal Medicine. McGraw Hill Inc, New York, 1994, pp 1810-1813
Mazoyer E, Toledano SL, Rendu F, Hermant L, Lu H, Fiat A, Jolles P, Caen J: KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction. Eur J Biochem 194: 43-49, 1990
Drouet L, Sollier CB, Cisse M, Pignaud G, Mazoyer E, Fiat AM, Jolles P, Caen J: The antithrombotic effect of KRDS, a lactotransferrin peptide, compared with RODS. Nouv Rev Fr Haematol 32: 59-62, 1990
Wu G, Ruan C, Drouet L, Caen J: Inhibition effects of KRDS, a peptide derived from lactotransferrin, on platelet function and arterial thrombus formation in dogs. Haemostasis 22: 1-6, 1992
Ramesh CV, Jayakumar R, Kamini NR, Puvanakrishnan R: A process for the preparation of a novel peptide derivative exhibiting in vitro inhibition of platelet aggregation and antimicrobial activity. Indian Patent Application No. 1261/DEL/97.
Wexler BC, Kittinger GW: Myocardial necrosis in rats. Serum enzymes, adrenal steroid and histopathological alterations. Circ Res 13: 159-171, 1963
Besbasi FS, Hamlin RS: Influence of phenytoin on isoproterenol induced myocardial fibrosis in rats. Am J Vet Res 51: 36-39, 1990
King J: A routine method for the estimation of lactate dehydrogenase activity. J Med Lab Tech 16: 265-272, 1959
Judd JT, Wexler BC: Prolyl hydrolase and collagen metabolism after experimental myocardial infarction. Am J Physiol 228: 212-216, 1975
Bednar M, Smith B, Pinto A, Mullane KM: Nafazatrom induced salvage of ischemic myocardium in anesthetized dogs is mediated through inhibition of neutrophil function. Circ Res 57: 131-141, 1985
Kela AK, Reddy PL, Thombre DP: ECG findings in normal rats and after administration of isoproterenol. Ind J Physiol Pharmacol 24: 84-90, 1980
Ravichandran LV, Puvanakrishnan R, Joseph KT: Influence of isoproterenol induced myocardial infarction on certain glycohydrolases and cathepsins in rats. Biochem Med Metab Biol 45: 6-15, 1991
Mair J, Wagner I, Jakob G, Lechleitner P, Drenstl F, Puschendorf B, Michel G: Different time courses of cardial contractile proteins after acute myocardial infarction. Clin Chim Acta 231: 47-60, 1994
Noronha-Dutra AA, Steen EM, Woolf N: The early changes induced by isoproterenol in the endocardium and adjacent myocardium. Am J Pathol 114: 231-239, 1984
Zama N, Towns RLR: Effect of isoproterenol (ISO) on rat heart, liver, kidney, and muscle tissue levels of zinc, copper, and magnesium. Biol Trace Element Res 10: 189-199, 1986
Parratt JR, Szekeres L: Delayed protection of the heart against ischaemia. Trends Pharmacol Sci 16: 351-355, 1995
White FP, White SR: Isoproterenol induced myocardial necrosis is associated with stress protein synthesis in rat heart and thoracic aorta. Cardiovasc Res 20: 512-515, 1986
Haft JI, Kranz PD, Albert FJ, Fani K: Intravascular platelet aggregation in the heart induced by norepinephrine. Circ XLVI: 698-708, 1972
Wang D, Pabst KM, Adia Y, Pabst MJ: Lipopolysaccharide inactivating activity of neutrophils is due to lactoferrin. J Leukoc Biol 57: 865-874, 1995
Levy Toledano S, Grelac F, Caen JP, Maclouf J: KRDS, a peptide derived from human lactotransferrin, inhibits thrombin-induced thromboxane synthesis by cycloxygenase independent mechanism. Thromb Haemost 73: 857-861, 1995
Leveugle B, Mazurier J, Legrand D, Mazurier C, Montreuil J, Spik G: Lactotransferrin binding to its platelet receptor inhibits platelet aggregation. Eur J Biochem 213: 1205-1211, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ramesh, C.V., Malarvannan, P., Jayakumar, R. et al. Effect of a novel tetrapeptide derivative in a rat model of isoproterenol induced myocardial necrosis. Mol Cell Biochem 187, 173–182 (1998). https://doi.org/10.1023/A:1006835526608
Issue Date:
DOI: https://doi.org/10.1023/A:1006835526608